Step by Step

INTRODUCTION

ABIM MOC Activity ID

3/26/2019 - Medical Grand Rounds: Gastroenterology, Hepatology and Nutrition Year in Review

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Identify indications for PPI use, including the AspECT trial data and the SUP-ICU trial data.
  • Evaluate articles published in the past year dealing with PPI safety related to risk of dementia, bone fracture, and kidney disease in the context of previous published literature.
  • Determine the risk of reactivation of Hepatitis C therapy during chemotherapy
  • Realize the relative risk associated with the long term use of the older formulation of tenofovir (TDF) vs the newer formulation (TAF)
  • Evaluate the proposed risk score for HE in cirrhosis

Suggested Additional Reading:

  1. Jankowski JAZ, de Caestecker J, Love SB, et al. Esomeprazole and aspirin in Barrett's oesophagus (AspECT) a randomized factorial trial. Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26.
  2. Krag M, Marker S, Perner A, et al. Pantoprazole in Patients in Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med 2018; 379:2199-2208. DOI: 10.1056/NEJMoa1714919
  3. Gromm, et al. JAMA Neurol. 2016 Apr;73(4):410-6.
  4. Kamal, et al. J Clin Gastroenterol 2018;52:468–476
  5. Tapper EB, Parikh ND, Sengupta N, et al. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis. Hepatology. 2018 Oct;68(4):1498-1507. doi: 10.1002/hep.29628. Epub 2018 May 14.
  6. Agarwal K, Brunetto M, Seto WK, et al. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17.

Authors:
Kenneth Fasanella, MD — Assistant Professor of Medicine Program Director, Gastroenterology Fellowship Division of Gastroenterology, Hepatology and Nutrition
Dr. Fasanella is a consultant with Lygenesis, Inc.
Naudia Jonassaint, MD, MHS — Assistant Professor of Medicine Medical Director, Hepatology, Division of Gastroenterology, Hepatology and Nutrition Vice Chair for Diversity and Inclusion, Department of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh is an affirmative action, equal opportunity institution.